Previous 10 | Next 10 |
Summary Welcome to the first ever Psychedelic Sunday episode! There is a lot of overlap between the cannabinoid and psychedelic experiences and today we launch our coverage of the psychedelics industry. Challenges and opportunities within psychedelics. Highlighting 4 stocks: Com...
Psychedelics are all the rage right now. After seeing their heyday in the 1960s and 1970s, psychedelics spent decades in relative obscurity after federal and state governments opted to ban their production and consumption. However, a surge in psychedelic interest has recently seen... Read ...
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference Canada NewsWire NEW YORK , Dec. 1, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical ...
Psychedelics have seen a resurgence in scientific and mainstream interest over the past few years. The result has been an increasing body of research showing that psychedelics can have positive mental health impacts , especially when paired with psychiatry. With the public becoming more awa...
Like a can’t-look-away real-life soap opera, the MindMed drama is slipping into a chapter of fresh accusations. MindMed investors Jake Freeman and Chad Boulanger of FCM MM Holdings LLC, sent a letter on Nov. 14 to the MindMed’s (Nasdaq: MNMD) Carol Vallone, c...
After prohibitionist laws made it nearly impossible to study psychedelics for decades, researchers can now finally study these substances and their effects, thanks to loosening drug laws. In what has been called the psychedelic renaissance, researchers have significantly stepped up their psy...
SHERIDAN, Wyo., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Today, FCM MM HOLDINGS, LLC (“FCM”) announces that it has sent a letter (the “Letter”) to the Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (“MindMed”, ...
MindMed to Participate in the Jefferies London Healthcare Conference Canada NewsWire NEW YORK , Nov. 11, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company devel...
By now, everybody in the psychedelics industry knows the story of lysergic acid diethylamide (LSD): discovered by Swiss chemist Albert Hoffman in 1938; consumed by counter culture of the late 1960s as a popular recreational drug; used in government acid experiments – which ...
Mind Medicine (MindMed), Inc. (MNMD) Q3 2022 Earnings Conference Call November 10, 2022, 08:30 ET Company Participants Robert Barrow - CEO & Director Schond Greenway - CFO Daniel Karlin - Chief Medical Officer Conference Call Participants Charles ...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...